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Photodynamic therapy is a cancer treatment based on the interaction of light, oxygen and a photosensitiser. Protoporphyrin.
IX is an endogenous photosensitiser derived from the pro-drug aminolaevulinic acid. Tumours contain areas of hypoxia and
hypoglycaemia. Tumour cells adapt to these conditions by stress protein induction which may induce resistance to cancer
therapies. The effect of chronic hypoglycaemia on sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro was
studied in MCF-7, human breast cancer cells. Following chronic exposure to 0, 1 or 25 mM, glucose, cells were treated with
aminolaevulinic acid and the generation of intracellular protoporphyrin. IX measured by spectrofluorimetry. Aminolaevulinic
acid-induced photodynamic therapy sensitivity was compared between cells following chronic exposure to 0, 1 or 25 mM
glucose. Percentage cell survival was determined by clonogenic assay. Cells cultured in low glucose generated higher levels of
protoporphyrin IX compared to standard glucose medium (0 mM glucose: 0.8861075 ng cell71, 1 mM:
0.8661075 ng cell71, 25 mM: 0.60561075 ng cell71, P50.05). However, photodynamic therapy sensitivity was reduced
in glucose deprived cells (0 mM glucose: 61% survival, 1 mM: 80.5% and 25 mM: 39.6%, P50.05). Chronic exposure to low
glucose induces photodynamic therapy resistance despite increased intracellular concentrations of protoporphyrin IX and may
reflect cellular adaptation to chronic glucose deprivation.
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Photodynamic therapy (PDT), is a cancer treatment based on the
interaction of light, oxygen and a photosensitising chemical which
results in the generation of cytotoxic reactive oxygen species
(Weishaupt et al, 1976). Aminolaevulinic acid is the pro-drug for
the photosensitiser protoporphyrin IX (PpIX). Photodynamic ther-
apy has certain clinical limitations. Bulky tumours are difficult to
treat because of limited light penetration, but also due to biological
factors within the tumour. As the tumour mass increases, passive
diffusion is no longer adequate to supply metabolic demands
(Vaupel et al, 1989). Tumours therefore induce their own microcir-
culation (angiogenesis) but despite this, areas with low levels of
oxygen and essential nutrients persist (Gullino et al, 1967; Wend-
ling et al, 1984). Glucose levels in normal tissues are
approximately 5 mM, whereas values for tumours are usually
between 0 to 2 mM (Gullino et al, 1967). Low tumour glucose
levels are exacerbated because tumour cells preferentially metabo-
lise glucose by either aerobic or anaerobic glycolysis, rather than
by oxidative phosphorylation (Warberg, 1956). This is thought to
be due to gene mutations influencing the expression of the key
regulatory enzymes of glycolysis (Vora et al, 1985; Hue and Rous-
seau, 1993; Chesney et al, 1999), which results in increased glucose
utilisation rates per gram of tissue (Rofe et al, 1988; Heacock and
Sutherland, 1990).
Tumour cells may have an increased ability to withstand the
resulting adverse conditions. For example mutation of the p53
gene allows cells to continue proliferating despite hypoxia (Grae-
ber et al, 1996). Although less well studied, there is recent
evidence that similar genes in cancer cells may exist which facil-
itate tolerance to nutrient starvation (Izuishi et al, 2000), such
as bcl-2 (Lee et al, 1997; Shim et al, 1998). When a cell is exposed
to nutrient starvation, the cellular energy expenditure is down
regulated, primarily by a reduction in protein synthesis, decreased
ion channel activity and increased utilisation of endogenous trigly-
cerides (Culic et al, 1999). The cell induces a variety of stress
proteins, including glucose regulated proteins (GRPs), oxygen-
regulated proteins (ORPs), and heat shock proteins (HSPs), which
have a protective function and increase tolerance to hypoxia,
hypoglycaemia and certain anticancer therapies (Gazit et al,
1999; Yu et al, 1999). Glucose regulated proteins are constitutively
expressed at low levels, but on stimulation with a low glucose
level for over 24 h, levels may increase by as much as nine-fold
(Gazit et al, 1999).
Several groups have studied the effect of stress protein induc-
tion, on PDT sensitivity, which appears to be photosensitiser
dependent. Gomer et al (1991), demonstrated that cells treated
with the calcium ionophore A23187, an inducer of GRPs, were
significantly less sensitive to Photofrin-PDT. In direct contrast to
this, Morgan et al (1998), using the same GRP-inducer found
PDT sensitivity increased when using Victoria Blue BO (VBBO)
as the photosensitiser. The differences were attributed to the intra-
cellular localisation of the two sensitisers, with VBBO mainly
localised in the mitochondria and Photofrin II in multiple orga-
nelles. However, calcium ionophores have additional cellular
effects with innate cytotoxicity and influences on calcium levels
within the cell. This may influence the effect of PDT directly
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(Penning et al, 1992). There have been no published studies of the
effect of GRP induction on ALA-induced PDT.
The direct effect of glucose deprivation on ALA-induced PDT
has not been studied. This might be expected to elicit more
complex effects on the cell than simple induction of GRPs. On
exposure to glucose deprivation cells enter a phase of reduced
proliferation (Mazurek et al, 1998), and decreased energy expendi-
ture, with reduction in biosynthetic processes, as well as stress
protein induction. In extreme glucose starvation, direct cytotoxicity
may be observed. It is thought that under such circumstances,
there is an increased production of pro-oxidants by the mitochon-
dria, which exceeds the capacity of the free radical scavenging
mechanisms, resulting in cell death (Lee et al, 1998). Thus cyto-
toxicity induced by extreme glucose starvation, acts in a similar
way to PDT and may therefore potentiate efficacy.
The effect of increased glucose concentrations on the efficacy
and uptake of haematoporphyrin derivative on tumour cells has
been studied previously (Thomas and Girotti, 1989). Increasing
serum glucose levels enhanced the uptake of haematoporphyrin
derivative and cell killing by PDT, an effect attributed to the
decreased pH induced by the lactic acid generation as a conse-
quence of increased glycolysis. How such effects influence PpIX
generation may be predicted from previous in vitro work (Fuchs
et al, 1997; Wyld et al, 1998), suggesting that PpIX generation is
optimal between pH 7 and 7.5, decreasing at lower pH values.
Therefore the present study aimed to investigate the effects of
chronic glucose deprivation on ALA-induced photodynamic ther-
apy, the rate of intracellular PpIX generation, extra-cellular PpIX
accumulation and PDT sensitivity, using the human breast cancer
cell line MCF-7. MCF-7 breast cancer cells were selected for this
work due to their known sensitivity to glucose deprivation (Yama-
moto et al, 1999), and the use of clinical PDT in the treatment of
cutaneous breast cancer metastases (Mang et al, 1998).
MATERIALS AND METHODS
Cell lines
MCF 7. Human Mammary Carcinoma This cell line was
obtained from the European collection of Animal Cell Cultures
(ECACC, Porton Down, UK; Soule et al, 1973).
Cell culture techniques
Cells were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM, Gibco, UK) supplemented with 10% foetal calf serum
(Gibco, UK) and 1% penicillin and streptomycin solution (Gibco,
UK). Cells were maintained as exponentially growing monolayer
cultures at 378C in air supplemented with 5% carbon dioxide. Cells
were fed every 48 h and passaged once or twice weekly. Cell
cultures for passage were detached with trypsin 0.05% and EDTA
0.02% (Gibco, UK).
Standard culture medium contained 25 mM glucose. For chronic
glucose deprivation 0 and 1 mM glucose medium was used. In all
experimental media, dialysed foetal calf serum was used (Gibco,
UK).
Variation in cell viability and proliferation rates with
glucose concentration
Glucose concentrations which caused inhibition of basic metabolic
processes but which were not toxic to the cells were required for
this study. Low glucose concentrations in the range of 5 mM and
below cause induction of glucose regulated proteins after a 24 h
incubation (Mote et al, 1998). The normal glucose concentration
in culture medium for this cell line was 25 mM. Three glucose
concentrations were therefore studied: 25, 1 and 0 mM. The rate
of cellular proliferation and cell death was studied by culturing
cells in these media for up to 10 days by serial cell counting and
trypan blue staining. Growth curves were then plotted. Cells were
plated at three plating densities into the wells of a 24-well plate
(16103, 56103 and 16104 cells ml71). The cells were allowed
to attach for 24 h and the medium then replaced with one of
the three glucose media. A baseline cell count was performed by
trypsinising the cells in a well, staining with trypan blue and count-
ing using a Modified Neubauer Haemocytometer. At 24 h intervals
cells were harvested and counted. The cell number was then plotted
against time from plating to derive a cell growth curve. At all time
points three triplicate repeats for each glucose concentration were
studied.
Protoporphyrin IX determination
Cells were plated into 25 cm2 tissue culture flasks and allowed to
attach for 24 h. On the basis of the cell counting experiments, plat-
ing density was modified for different glucose media to give similar
cell densities at the time of assay. The standard culture medium
was then removed and replaced with, either: 25, 1 or 0 mM glucose
medium. The cells were then incubated for 48 h. The old medium
was then removed and replaced with, either: 25, 1 or 0 mM glucose
medium to which 1 mM ALA had been added and the cells incu-
bated in the dark for 4 h. The cells were then washed and
trypsinised and counted using a Neubauer Haemocytometer and
trypan blue to determine the number of viable cells per flask.
The concentration of PpIX in the medium was determined at the
end of the incubation period by mixing the medium with an equal
volume of methanol and perchloric acid. The protein precipitate
was removed by centrifugation and the fluorescence of the super-
natent determined on a spectrofluorimeter with excitation at
406 nm and emission at 604 nm (Perkin Elmer Ltd. UK). The
concentration of PpIX in the medium was then determined by
comparison with a standard curve of fluorescence against PpIX
concentration. This amount was then adjusted to reflect the
amount per viable cell.
The amount of intracellular PpIX was determined by first
homogenising the cell pellet using an UltraTurrax tissue homogeni-
ser (Janke and Kunkel, Germany), to disrupt the cell membranes.
The cell suspension was then mixed with methanol and perchloric
acid and the fluorescence of the resulting solution was read on the
spectrofluorimeter as above. Again values were corrected per viable
cell. For all experiments six triplicate repeats were performed
(N=18).
Photodynamic therapy sensitivity-clonogenicity assay
Cells were plated into 96-well plates at a cell density of 2 –
46104 cells ml71 and allowed to attach overnight. On the basis
of the cell counting experiments, plating density was modified
for different glucose medium to give similar cell densities at the
time of assay. The cells were then washed and incubated with
medium containing 25, 1 or 0 mM glucose for 48 h. One mM
ALA was added to the cells in fresh medium of the same glucose
concentration and incubated for 4 h in the dark at 378C. The cells
were then exposed to violet light (350 to 450 nm, 86.5 mW cm72),
at a light dose of 3 J cm72. (This dose was selected from prelimin-
ary experiments which caused approximately 50% cell death
response (LD 50) in cells cultured in normal glucose medium
(25 mM). The medium was then replaced with standard complete
medium without ALA, and the cells returned to the incubator
for 24 h. The cells were then trypsinised and re-plated into the
wells of 6-well plates and incubated for a further 4 days. At the
end of this period the cells were stained with trypan blue and
examined under a microscope and the number of viable colonies
of more than eight cells were counted in five randomly selected
high power fields per well. The mean of this value was taken. Three
triplicate repeats were performed for each glucose concentration in
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addition to the relevant controls for light alone, ALA alone and
neither light or ALA. Percentage cell survival was calculated relative
to the control cultured with the same glucose concentration.
Statistical analysis
Comparisons were with an initial analysis of variance
(ANOVA, Kruskall Wallace) followed by a Mann – Whitney
U-Test. Statistical significance was accepted if P50.05. All
data are represented as the mean plus standard error of the
mean (s.e.m).
RESULTS
Cell growth and viability
Following plating there was an initial slight reduction in cell
numbers at all plating densities.
Cells cultured in 25 mM glucose commenced active proliferation
within 48 h of plating which reached a maximum at day 6,
followed by a sudden decrease in cell numbers. This was accompa-
nied by a visible change in the pH of the culture medium,
suggesting a build up of lactic acid. For cells cultured under
reduced glucose concentrations, 0 and 1 mM, the increase in cell
numbers was delayed and peaked at day 5 at a significantly lower
level than in the 25 mM glucose medium (day 5 mean cell counts:
0 mM glucose: 3.836105 cells ml71, 1 mM glucose: 9.626105 cells
ml71 and 25 mM glucose: 29.266105 cells ml71, P50.05, Figure
1). After day 5 there was a reduction in cell numbers but unlike
in the high glucose medium, this was not accompanied by a
decrease in the pH of the medium (Figure 1).
Protoporphyrin IX levels following ALA incubation with
various glucose concentrations
Total PpIX generation Cells grown under conditions of chronic
glucose deprivation (0 and 1 mM glucose) produced significantly
more PpIX than those grown under normal conditions (P50.05,
Figure 2).
Intracellular PpIX levels Levels of intracellular PpIX were
lowest in the cells grown under normal tissue culture glucose
concentrations, highest in 1 mM glucose, although the differences
failed to reach statistical significance (Figure 2).
Extracellular PpIX levels Cells grown under conditions of
chronic glucose deprivation produced significantly more extracellu-
lar PpIX than those grown under normal conditions (P50.05,
Figure 2).
Photodynamic therapy sensitivity Following PDT, cells that
were treated under normal glucose conditions were significantly
more sensitive to ALA-induced PDT than cells treated under low
glucose conditions (0 and 1 mM glucose). The least sensitive cells
were those treated at 1 mM glucose, with cell exposed to 0 mM
glucose being intermediate in sensitivity (P50.05, Figure 3). There
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Figure 1 Graph showing cell growth curves for MCF-7 cells cultured in different glucose medium. Mean number of cells per well at different time intervals
after plating. Data shown represent means plus standard error of mean. n=9. *Denotes statistical significance compared to 25 mM glucose cultures, P50.05,
Mann – Whitney U-test.
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Figure 2 Graph showing PpIX levels following incubation of cells with 1 mM ALA after chronic exposure to varying glucose concentrations. Data shown
represent mean plus standard error of mean. n=18. *Denotes statistical significance compared to 25 mM glucose, P50.05, Mann – Whitney U-test.
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was no detectable toxicity in controls for ALA alone or light alone
treated controls.
DISCUSSION
This study has demonstrated for the first time that chronic exposure
to low glucose concentrations, at levels likely to be found in vivo
(Gullino et al, 1967), inhibits the effect of ALA-induced PDT in vitro.
The inhibition of response is most pronounced at 1 mM glucose
where cell cytotoxicity due to the direct effects of low glucose concen-
tration is not apparent. At zero mM glucose, cytotoxicity due to PDT
is increased when compared to cells incubated with 1 mM glucose,
but this is not as dramatic as the response of cells in normal glucose
medium. These data may suggest that the increased reactive oxygen
species generated by glucose deprivation itself (Lee et al, 1998),
may be potentiating the damage caused by PDT which is also due
to the production of reactive oxygen species (Weishaupt et al,
1976). This may be partially overcoming the protective effects of
GRP induction caused by total glucose deprivation.
The underlying reason for the reduction in PDT toxicity with
low glucose concentrations cannot be attributed to changes in
the intracellular concentration of PpIX, which has been previously
demonstrated to influence PDT sensitivity (Wyld et al, 1997), as
levels were lowest in the most sensitive cells, i.e. those treated
under normal glucose concentrations. The differences in intracellu-
lar PpIX generation were small and did not reach statistical
significance. The rate at which the cells generated PpIX (total
production, i.e. intracellular and medium), was actually increased
by chronic glucose deprivation, suggesting either induction of the
rate limiting enzyme, thought to be porphobilinogen deaminase
(Gibson et al, 1998), or a reduction in the rate of conjugation to
iron to form haem by the enzyme ferrochelatase. There was a
significant increase in the amount of PpIX in the medium, which
may reflect increased generation, but it is also possible that the rate
of PpIX leakage from the cells was increased. Cells exposed to
nutrient deprivation tend to conserve energy by reducing the activ-
ity of their ion channels (Culic et al, 1999), which may affect the
cells ability to retain intracellular molecules.
The effect of an acute reduction in glucose concentration on
PpIX generation from ALA has been studied previously and is
bi-phasic with maximal PpIX production at 2 mM, decreasing at
both higher (4 – 8 mM) and lower (0 mM) glucose concentrations
(Dietel et al, 1996). This study exposed the cells to the low glucose
concentration for up to 8 h, during which period the ALA was also
applied. It is unlikely that this period of time is long enough to
induce adaptive changes in the cells such as stress protein induc-
tion. This study only looked at total PpIX generated, with no
differentiation between intra and extracellular levels and PDT
sensitivity was not studied (Dietel et al, 1996).
The changes in the rate of PpIX generation cannot be attributed
to differences in cell density between the different glucose media.
Cell density is known to affect the rate of PpIX generation. Increas-
ing tumour cell density by a factor of 10 increases PpIX production
(Moan et al, 1998). The present results show a reverse trend in
PpIX production despite the higher density of cells in the high
glucose cells (306105 cells ml71 at 0 mM glucose vs
446105 cells ml71 at 25 mM glucose), suggesting the involvement
of additional processes.
The pH of the culture medium is unlikely to have contributed
to the differences in PpIX levels, as the medium was replaced at
the start of the 4 h ALA incubation period, and the lower pH value
would be expected in the most acidic flasks (Fuchs et al, 1997), i.e.
those with the highest glucose concentrations. The data show the
reverse trend.
These findings are of concern for clinical PDT. Those tumour
cells exposed to extreme nutrient deprivation often combined with
marked hypoxia for prolonged periods are usually not viable and
undergo spontaneous cell death. However, cells in less extreme
conditions of nutrient deprivation are likely to develop tolerance
to the effect of PDT, due to GRP induction. These nutritionally
deprived cells are known to have an increased metastatic potential
(Schlappack et al, 1991), and may therefore serve as resistant foci
for tumour progression. Unlike the problem of hypoxic inhibition
of PDT (Mitchell et al, 1985; Wyld et al, 1998), there is a potential
solution; infusions of glucose may elevate tumour glucose levels
appreciably and therefore reduce the proportion of hypoglycaemic
cells. The effect of glucose infusions on Photofrin-PDT have been
studied previously and hyperglycaemia enhanced the uptake of
Photofrin by the target tissue and increased PDT sensitivity
(Thomas and Girotti, 1989). The reason for this effect was
suggested to be due to the decrease in pH, which accompanied
excess glucose due to its conversion to lactate.
The effect of different glucose concentrations on cellular prolif-
eration rates was predictable. MCF-7 cells are known to be
relatively intolerant of low glucose levels, and at concentrations
of 5 mM and below, undergo a significant reduction in prolifera-
tion (Yamamoto et al, 1999). In the current study the effect at
zero glucose concentration after 6 days demonstrates that these
cells are unable to survive long term without glucose. After 48 h
in low glucose concentrations, the added insult of PDT induces cell
death, demonstrating that the protective effect of chronic adapta-
tion to glucose deprivation is overwhelmed.
In summary therefore, this study presents the first report of the
effect of chronic glucose deprivation on the sensitivity of breast
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Figure 3 Graph showing percentage survival following PDT after incubation at different glucose concentrations compared to untreated controls. Data
represent mean plus standard error of mean. N=9. *Represents statistical significance compared to the value at 25 mM glucose, P50.05, Mann – Whitney
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cancer cells to photodynamic therapy. Chronic exposure to low
glucose levels has a protective effect on the cells, possibly due to
induction of stress proteins, but this requires further study. This
may inhibit the efficacy of ALA-PDT in the treatment of bulky
tumours and further work is needed to assess whether induction
of transient hyperglycaemia may reverse this. It must also be
remembered that low glucose and hypoxia usually co-exist and as
both have an inhibitory effect, this suggests that PDT for bulky
tumours may have inherent limitations.
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